Immuron’s shares rise on the back of Travelan® results

Australian biopharmaceutical group, Immuron Ltd (ASX:IMC; NASDQ:IMRN), has provided an extremely promising update on the company’s cooperative research and development agreements with the US Department of Defence, no doubt contributing to its strong share https://finfeed.com/small-caps/biotech/immurons-shares-rise-on-the-back-of-travelan-results/

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.